Reply from the authors

Neurology

Volumn 74, Issue 19, 2010, Pages 1556-

  Larriviere, Dan ^a   Williams, Michael A ^a   Rizzo, Matt ^a   Bonnie, Richard J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; NEUROENHANCER; UNCLASSIFIED DRUG;

DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MEDICAL ETHICS; MEDICAL SOCIETY; PATIENT COUNSELING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL ASPECT; TRADITIONAL MEDICINE;

EID: 77952199135     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d8a66a     Document Type: Letter

References (4)

1. Larriviere D, Williams MA, Rizzo M, Bonnie RJ, on behalf of the AAN Ethics, Law and Humanities Committee. Responding to requests from adult patients for neuroen-hancements: Guidance of the Ethics, Law and Humanities Committee. Neurology 2009;73:1406-1412
2. Commission de l'Éthique de la Science et de la Technologie. Position Statement on Psychotropic Drugs and Expanded Uses: An Ethical Perspective. Quebec: Government of Quebec; 2009.
3. Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008;456:872.
4. Racine E. Pragmatic Neuroethics: Improving Treatment and Understanding of the Mind-Brain. Cambridge, MA: MIT Press; 2010.